Bio-Rad Laboratories Class A
193 hedge funds and large institutions have $2.32B invested in Bio-Rad Laboratories Class A in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 66 increasing their positions, 71 reducing their positions, and 20 closing their positions.
70% more call options, than puts
Call options by funds: $698K | Put options by funds: $410K
3% more capital invested
Capital invested by funds: $2.25B → $2.32B (+$65.7M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.77% less ownership
Funds ownership: 77.21% → 76.44% (-0.77%)
5% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 20
7% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 71
3% less funds holding
Funds holding: 198 → 193 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$32.5M |
| 2 |
HIM
Hermes Investment Management
London Uk,
United Kingdom
|
+$32.1M |
| 3 |
LCS
Levin Capital Strategies
New York
|
+$19.6M |
| 4 |
SAM
Sentinel Asset Management
Montpelier,
Vermont
|
+$16.6M |
| 5 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$13.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$46.4M |
| 2 |
RA
Royce & Associates
New York
|
-$25.2M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$24.5M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$15.6M |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$11.9M |
BIO Hedge Fund Activity: Q1 2014 in Review
193 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q1 2014, worth a combined $2.32B — up 2.9% from $2.25B a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of BIO and 19 opened new positions — a net loss of 1 holder — while 71 trimmed existing stakes and 66 added.
The largest buyer was Wells Fargo, adding an estimated $32.5M. The largest seller was Morgan Stanley, cutting an estimated $46.4M.
- 193 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q1 2014, down from 198 in Q4 2013.
- Funds reported $2.32B of Bio-Rad Laboratories Class A stock for Q1 2014, up 2.9% quarter-over-quarter.
- 19 funds opened new Bio-Rad Laboratories Class A positions in Q1 2014 and 20 closed out, a net change of -1 holder.
- The largest Bio-Rad Laboratories Class A buyer in Q1 2014 was Wells Fargo, an estimated $32.5M added.
- The largest Bio-Rad Laboratories Class A seller in Q1 2014 was Morgan Stanley, an estimated $46.4M sold.
Based on aggregated 13F filings for Q1 2014.